November 22, 2017 | The Shenzhen-listed, China-based pharmaceutical firm Chengdu Kanghong Pharma Group will acquire Israeli medtech company IOPtima in four stages. BioLight Life Sciences, the parent company of IOPtima, announced the acquisition through the Tel Aviv Stock Exchange. In the first stage, Chengdu Kanghong Pharma will buy 19% of IOPtima’s stock for $7 million. […]